MSB 6.07% $1.01 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-551

  1. 30,335 Posts.
    lightbulb Created with Sketch. 1837
    This is only an advisory committee and it's the first stem cell approval application so they're being bureaucrats and scared of what they don't fully understand. Oddly enough some of the nayasyers in here have referred to these claims before..

    Storm in a teacup but great for the shorters.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.01
Change
-0.065(6.07%)
Mkt cap ! $1.147B
Open High Low Value Volume
$1.05 $1.05 99.5¢ $9.449M 9.298M

Buyers (Bids)

No. Vol. Price($)
2 64999 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.02 64541 3
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.